Differential efficacy of gonadotropin-releasing hormone (GnRH) agonist treatment on pedunculated and degenerated myomas: a retrospective study of 630 women

By Furui T.   Imai A.   Takagi A.   Tamaya T.   Takagi H.   Matsunami K.   Shiraki S.  

Journal of Obstetrics & Gynaecology, Vol. 20, Iss. 5, 2000-09 ,pp. : 504-506

Informa Healthcare

Access to resources Recommend Favorite

GnRH agonist therapy and the use of sex steroid add-back: improving the product

By Olive David L  

Expert Review of Obstretrics and Gynecology, Vol. 6, Iss. 6, 2011-11 ,pp. : 583-585

Informa Healthcare

Access to resources Recommend Favorite

Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor

By Shozu M.   Murakami K.   Segawa T.   Kasai T.   Inoue M.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 628-631

Elsevier

Access to resources Recommend Favorite

Modified Natural Cycle Using GnRH Antagonist Can Be an Optional Treatment in Poor Responders Undergoing IVF

By Elizur Shai   Aslan Dilek   Shulman Adrian   Weisz Boaz   Bider David   Dor Jehoshua  

Journal of Assisted Reproduction and Genetics, Vol. 22, Iss. 2, 2005-02 ,pp. : 75-79

Springer Publishing Company

Access to resources Recommend Favorite

Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment

By Ito F.   Kawamura N.   Ichimura T.   Tsujimura A.   Ishiko O.   Ogita S.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 125-130

Elsevier

Access to resources Recommend Favorite